Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Category | Mid Cap | Mid Cap |
| Plan | Direct | Direct |
| Fund house | UTI | Nippon India |
| NAV | ₹352.1748 | ₹4,949.4053 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 13.9 years | 13.9 years |
| Expense ratio | 1.3% | 0.8% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 15.40 | 65.70 |
Returns
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| 1 month | +5.25% | +5.45% |
| 3 months | −2.53% | −2.03% |
| 6 months | +4.40% | +2.57% |
| YTD | +3.72% | +6.56% |
| 1 year | +2.51% | +5.19% |
| 3 years (CAGR) | +11.41% | +16.47% |
| 5 years (CAGR) | +10.97% | +17.01% |
| 10 years (CAGR) | +15.17% | +19.06% |
| Since launch | +17.74% | +17.82% |
Risk
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Volatility | 18.0% | 17.9% |
| Downside volatility | 12.6% | 11.7% |
| Sharpe | 0.27 | 0.56 |
| Sortino | 0.39 | 0.85 |
| Calmar | 0.50 | 0.83 |
| Return / risk | 0.64 | 0.92 |
| Deepest fall | −40.75% | −35.32% |
| Days to recover | 239 | 224 |
| Below its high | −3.06% | −2.58% |
Against benchmark
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Alpha | −1.83% | +2.40% |
| Beta | 0.96 | 0.96 |
| R² | 95.5% | 95.9% |
| Up capture | 93.5% | 100.8% |
| Down capture | 100.4% | 90.2% |
| Tracking error | 3.9% | 3.7% |
| Information ratio | −0.55 | 0.56 |
| Treynor | 0.04 | 0.09 |
Consistency
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Best 1-year | +127.40% | +96.36% |
| Middle 1-year | +15.20% | +15.30% |
| Worst 1-year | −28.62% | −27.61% |
| 1-year periods with a loss | 17.7% | 13.6% |
| Middle 3-year | +18.25% | +21.76% |
| Positive months | 58.3% | 69.4% |
| Best day | +3.74% | +4.57% |
| Worst day | −5.11% | −7.42% |
| Worst 5% day | −1.77% | −1.82% |
| Positive days | 56.8% | 54.9% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| 5-year XIRR | +11.66% | +17.42% |
| 5-year value | ₹8,09,045 | ₹9,34,974 |
| 3-year XIRR | +6.74% | +10.20% |
| 1-year XIRR | +7.79% | +8.03% |
Holdings overlap i
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| UTI - Mid Cap Fund | — | 32% |
| Nippon India Growth Mid Cap Fund | 32% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund |
|---|---|---|
| AU Small Finance Bank Limited | 2.47% | 2.49% |
| Info Edge (India) Limited | 2.31% | 2.55% |
| Persistent Systems Limited | 1.81% | 2.03% |
| One 97 Communications Limited | 1.80% | 2.37% |
| The Federal Bank Limited | 1.76% | 2.85% |
| Bharat Heavy Electricals Limited | 1.71% | 1.35% |
| Gland Pharma Limited | 1.31% | 1.77% |
| APL Apollo Tubes Limited | 1.81% | 1.28% |
| IPCA Laboratories Limited | 1.42% | 1.22% |
| Max Financial Services Limited | 1.31% | 1.20% |
| Ashok Leyland Limited | 1.37% | 1.10% |
| Indian Bank | 1.57% | 1.08% |
| Multi Commodity Exchange of India Limited | 1.05% | 3.20% |
| Lupin Limited | 1.15% | 0.90% |
| Torrent Power Limited | 1.43% | 0.84% |
| Balkrishna Industries Limited | 1.08% | 0.83% |
| Bharat Electronics Limited | 1.12% | 0.76% |
| Swiggy Limited | 0.69% | 0.87% |
| ZF Commercial Vehicle Control Systems India Limited | 0.67% | 0.88% |
| Schaeffler India Limited | 1.45% | 0.66% |
| Tube Investments of India Limited | 0.64% | 1.26% |
| Mphasis Limited | 0.87% | 0.61% |
| Blue Star Limited | 2.81% | 0.60% |
| Endurance Technologies Limited | 0.62% | 0.60% |
| Vishal Mega Mart Limited | 1.09% | 0.60% |
Sectors and company size
| UTI - Mid Cap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Large companies | 11.1% | 22.4% |
| Mid companies | 65.4% | 66.0% |
| Small companies | 20.6% | 11.5% |
| Top 10 holdings | 22.9% | 25.7% |
| Largest sector | Pharmaceuticals & Biotechnology 10% | Banks 10% |